Navigation Links
Advinus Therapeutics, a TATA Enterprise, Meets Milestone in Drug Discovery Alliance
Date:1/11/2016

PUNE, India, January 11, 2016 /PRNewswire/ --

Advinus Therapeutics Ltd., the TATA promoted pharmaceutical R&D company, announced today that it has reached the third milestone in its research and development collaboration with Takeda Pharmaceutical Company Limited. The achievement of this milestone highlights the success of the collaboration.

In October 2012, Advinus and Takeda announced a multi-year, multi-project collaboration in the area of drug discovery. In this collaboration, Advinus is responsible for carrying out all the research required to identify candidate molecules for clinical development in several therapeutic areas while Takeda is responsible for the development and commercialization of these candidates. In each of the previous two years, Advinus has met predetermined milestones. The achievement of the third milestone underscores the rapid progress of the research programs over the past year, a result of the innovative solutions and the speed and quality of Advinus' efforts supported by Takeda's guidance and highly interactive engagement.

"The achievement of the third milestone by Advinus' young and talented scientists is a clear demonstration of how an effective partnership could deliver novel and effective candidates for drug development in a cost effective manner," said Kasim Mookhtiar, CEO & MD of Advinus.

About Advinus:  

Advinus Therapeutics is a research-based pharma company promoted by the TATA group. The company is the first-of-its-kind in India to offer end-to-end development services to the global pharma, agro and biotech industry while creating long-term value through internal and collaborative drug discovery. The primary focus of the company's discovery efforts are in Metabolic Diseases, Inflammatory Diseases and Pain/Neurodegeneration. Advinus also has an interest in pursuing the discovery of novel therapies for neglected or developing world diseases. Advinus' drug development operations supports and supplements the client resources at increased levels of cost-efficiency by providing services in the areas of Process Development, Drug Metabolism and Pharmacokinetics, Clinical Pharmacology, Safety Assessment, Formulation Development and Analytical R&D.

For company information, visit Advinus at http://www.advinus.com.

Media Contact:
Advinus
Joshua Daniel
Corporate Communications
+91-80-66553104
http://www.advinus.com


'/>"/>
SOURCE Advinus Therapeutics Ltd
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Advinus Therapeutics, a TATA Enterprise, Meets Year 1 Milestone in Drug Discovery Alliance
2. Advinus Therapeutics, A TATA Enterprise, Meets Milestone in Drug Discovery Alliance
3. PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Signature Therapeutics, Inc., Presents Four Scientific Posters Today at PAINWeek 2013 Meeting
6. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
7. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Osiris Therapeutics, Inc.
8. Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Repros Therapeutics, Inc.
9. Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws
10. Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
11. Inhibikase Therapeutics, Inc. Elects Anthony Zook To The Board Of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... (PRWEB) , ... July 10, 2020 , ... ... board-certified gynecologist, Dr. Lillian DeCosimo in partnership with Dr. Shashi Kusuma, a plastic ... the launch of Suria Women’s Health division. This service/treatment is a first-of-its-kind specifically ...
(Date:7/10/2020)... , ... July 10, 2020 , ... ... new guidance for HIPAA Compliance for Business Associates. Business associates create, receive, transmit, ... clients. As such, business associates are required to be HIPAA compliant, ensuring the ...
(Date:7/10/2020)... ... ... The team at The Keyhole Heart Clinic have been hard ... offers a multitude of user enhancements and streamlined navigation for a more intuitive user ... menus which will allow patients to find the information they need quickly. Of particular ...
Breaking Medicine Technology:
(Date:8/3/2020)... ... August 03, 2020 , ... The process uses ... House, Google, Amelia Arena, the Phoenix airport, the Mayo Clinic, Ramstein Air Force ... to Global Plasma Solutions (GPS), the manufacturers of the system, most viruses and ...
(Date:7/31/2020)... ... July 31, 2020 , ... ... is announcing an expansion of clinical & technical capabilities to cover the full ... complete back and joint health solution. , Currently, employers interested in truly ...
(Date:7/22/2020)... ... July 22, 2020 , ... ... Black Lives Matter movement, the world has changed, and there’s no going back. ... healing. While coping mechanisms help us temporarily manage emotional struggles, healing is the ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... A June 2 article on ... to seek help for her mishandled breast augmentations. The article says that her first procedure, ... had assumed. The woman then found a surgeon to revise her procedure, only to find ...
(Date:7/18/2020)... ... , ... Nader Sanai, M.D., director of the Ivy Brain Tumor Center at ... Glioblastoma Awareness Day (#GBMDay) on July 22, 2020 to raise national consciousness. , ... , the most common and aggressive form of brain cancer. It also honors those ...
Breaking Medicine News(10 mins):